Topical Pain Relief Market Analysis

  • Report ID: 2473
  • Published Date: May 21, 2025
  • Report Format: PDF, PPT

Topical Pain Relief Segmentation

Product Segment Analysis

Based on product, the patches segment is expected to garner the highest share of 32.8% in the topical pain relief market by the end of 2037. The dominance of the segment is attributable to the fast-rising demand for pain relief therapeutics among the aging population across the world due to their higher efficacy. Besides, in 2023 CDC states that 25.3% of adults in the U.S will be using the pain relief patches by 2030. Moreover, the governing bodies, such as the U.S. FDA, are offering support with fast-track designations, thus augmenting the segment’s growth.

Distribution Channel Segment Analysis

Based on the distribution channel, the over-the-counter segment is projected to grow at a considerable rate in the topical pain relief market during the forecast period. In this regard, as per a WHO report in 2024, the dominance of the segment is attributable to the self-care trends and convenience, particularly in developing nations such as India and China, where maximum sort of topical pain relief therapeutics is purchased without any prescription. Moreover, it allows for to conservation of nearly USD 25.6 billion by reducing the medical visits.

Our in-depth analysis of the global topical pain relief market includes the following segments:

Product

  • Patches
  • Creams
  • Gels
  • Sprays

Distribution Channel

  • Over-the-Counter (OTC)
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

Therapeutic Class

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Local Anesthetics
  • Capsaicin
  • Counterirritants

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of topical pain relief is assessed at USD 13.8 billion.

Topical Pain Relief Market size was valued at USD 12.9 billion in 2024 and is expected to reach USD 25.4 billion by 2037, expanding at around 6.2% CAGR during the forecast period i.e., between 2025-2037.

North America industry is set to account for largest revenue share of 40.8% by 2037.

The major players in the market are Reckitt Benckiser Group plc, Teikoku Pharma USA, Inc., Topical BioMedics, Inc., Sun Pharmaceutical Industries Ltd., AdvaCare Pharma®, Sanofi, Johnson & Johnson Services, Inc., Novartis AG,
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos